These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 8208339

  • 21. Desferrioxamine-induced changes of aluminium kinetics during haemodialysis.
    Graf H, Stummvoll HK, Meisinger V.
    Proc Eur Dial Transplant Assoc; 1981; 18():674-80. PubMed ID: 7329995
    [Abstract] [Full Text] [Related]

  • 22. Aluminium, neurofibrillary degeneration and Alzheimer's disease.
    Crapper DR, Krishnan SS, Quittkat S.
    Brain; 1976 Mar; 99(1):67-80. PubMed ID: 963531
    [Abstract] [Full Text] [Related]

  • 23. Quantitative studies on aluminum deposition and its effects on neurofilament protein expression and phosphorylation, following the intraventricular administration of aluminum maltolate to adult rabbits.
    Savory J, Herman MM, Hundley JC, Seward RL, Griggs CM, Katsetos CD, Wills MR.
    Neurotoxicology; 1993 Mar; 14(1):9-12. PubMed ID: 8361684
    [Abstract] [Full Text] [Related]

  • 24. Treatment of aluminium intoxication: a new scheme for desferrioxamine administration.
    Douthat WG, Acuña Aguerre G, Fernández Martín JL, Mouzo R, Cannata Andía JB.
    Nephrol Dial Transplant; 1994 Mar; 9(10):1431-4. PubMed ID: 7816256
    [Abstract] [Full Text] [Related]

  • 25. Molecular toxicity of aluminium in relation to neurodegeneration.
    BharathiDepartment of Biochemistry & Nutrition, Central Food Technological Research Institute, CSIR, Mysore, India., Vasudevaraju P, Govindaraju M, Palanisamy AP, Sambamurti K, Rao KS.
    Indian J Med Res; 2008 Oct; 128(4):545-56. PubMed ID: 19106446
    [Abstract] [Full Text] [Related]

  • 26. Ultrafiltrable aluminium after very low doses of desferrioxamine.
    Canteros A, Díaz-Corte C, Fernández-Martín JL, Gago E, Fernández-Merayo C, Cannata J.
    Nephrol Dial Transplant; 1998 Jun; 13(6):1538-42. PubMed ID: 9641189
    [Abstract] [Full Text] [Related]

  • 27. Progressing encephalomyelopathy with muscular atrophy, induced by aluminum powder.
    Bugiani O, Ghetti B.
    Neurobiol Aging; 1982 Jun; 3(3):209-22. PubMed ID: 7162550
    [Abstract] [Full Text] [Related]

  • 28. Aluminium and the neurofibrillary tangle: results of tissue microprobe studies.
    Perl DP, Good PF.
    Ciba Found Symp; 1992 Jun; 169():217-27; discussion 227-36. PubMed ID: 1490424
    [Abstract] [Full Text] [Related]

  • 29. EXPERIMENTAL PRODUCTION OF NEUROFIBRILLARY DEGENERATION 2. ELECTRON MICROSCOPY, PHOSPHATASE HISTOCHEMISTRY AND ELECTRON PROBE ANALYSIS.
    TERRY RD, PENA C.
    J Neuropathol Exp Neurol; 1965 Apr; 24():200-10. PubMed ID: 14280497
    [No Abstract] [Full Text] [Related]

  • 30. Successful treatment of aluminium encephalopathy by intraperitoneal desferrioxamine.
    Payton CD, Junor BJ, Fell GS.
    Lancet; 1984 May 19; 1(8386):1132-3. PubMed ID: 6144870
    [No Abstract] [Full Text] [Related]

  • 31. Binding of aluminium to plasma proteins: comparative effect of desferrioxamine and deferiprone (L1).
    Fernández-Martín JL, Menéndez-Fraga P, Canteros MA, Díaz-López JB, Cannata-Andía JB.
    Clin Chim Acta; 1994 Oct 31; 230(2):137-45. PubMed ID: 7834865
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Neurochemical characteristics of aluminum-induced neurofibrillary degeneration in rabbits.
    Beal MF, Mazurek MF, Ellison DW, Kowall NW, Solomon PR, Pendlebury WW.
    Neuroscience; 1989 Oct 31; 29(2):339-46. PubMed ID: 2566953
    [Abstract] [Full Text] [Related]

  • 37. Exacerbation of aluminium encephalopathy after treatment with desferrioxamine.
    Lillevang ST, Pedersen FB.
    Nephrol Dial Transplant; 1989 Oct 31; 4(7):676. PubMed ID: 2510071
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Absence of aluminium in neuritic plaque cores in Alzheimer's disease.
    Landsberg JP, McDonald B, Watt F.
    Nature; 1992 Nov 05; 360(6399):65-8. PubMed ID: 1436075
    [Abstract] [Full Text] [Related]

  • 40. Aluminum-induced neurofibrillary changes in axons and dendrites.
    Wisniewski HM, Shek JW, Gruca S, Sturman JA.
    Acta Neuropathol; 1984 Nov 05; 63(3):190-7. PubMed ID: 6464675
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.